An evidence-based update on the pharmacological activities and possible molecular targets of lycium barbarum polysaccharides

Medicine & Life Sciences

• lycium barbarum polysaccharide 100%
• Pharmacology 38%
• Lycium 36%
• Clinical Studies 9%
• Fruit 8%
• Poisons 6%
• Sperm Motility 5%
• Lymphokines 5%
• Retinal Ganglion Cells 5%
• Lateral Ventricles 4%
• Medicinal Plants 4%
• Neurogenesis 4%
• Dietary Supplements 4%
• Insulin Secretion 4%
• Cell Cycle Checkpoints 4%
• Wounds and Injuries 4%
• Neoplasms 4%
• Reproduction 4%
• Hypoglycemic Agents 4%
• Amyloid 4%
• Glaucoma 4%
• Nude Mice 4%
• Testis 3%
• Interleukin-2 3%
• Glutamic Acid 3%
• Reperfusion 3%
• Antiviral Agents 3%
• Theoretical Models 3%
• China 3%
• Hippocampus 3%
• Alzheimer Disease 3%
• Anti-Inflammatory Agents 3%
• Learning 3%
• Memory 3%
• Insulin 3%
• Aptitude 3%
• Healthy Volunteers 2%
• Cell Proliferation 2%
• Peptides 2%
• Glucose 2%
• Apoptosis 2%
• Drug Therapy 2%
• Safety 2%
• Liver 2%
• Growth 2%
• Health 2%
• In Vitro Techniques 1%
• Therapeutics 1%

Chemical Compounds

• Polysaccharide 49%
• Excitotoxicity 7%
• Cardioprotective 6%
• Hypolipidemic 6%
• Antiaging 6%
• Neurotoxic 5%
• Antidiabetic Agent 5%
• Retinal 5%
• Toxic Substance 4%
• Insulin Derivative 4%
• Antiinflammatory 4%
• Antitumor 4%
• Safety 3%
• Pharmacological Metabolism 3%
• Antioxidant Agent 3%
• Toxic 3%
• Glucose 3%
• Food 3%
• Peptide 2%